Global oil benchmark Brent surged to $93 per barrel on Wednesday due to heightened concerns about escalating conflict in the Middle East, which threatened to disrupt oil supplies from the region. The
MoreCitadel Securities and the American Securities Association (ASA) have jointly filed a lawsuit against the U.S. Securities and Exchange Commission (SEC) in the U.S. Court of Appeals for the 11th Circuit in
MoreHyloris Pharmaceuticals, headquartered in Belgium, announced on Wednesday that the U.S. health regulator has granted approval for their post-operative pain relief drug. The company anticipates launching this non-opioid treatment, known as Maxigesic
MoreJupiter Fund Management (JUP.L) experienced a historic low in its stock value on Tuesday, as it grappled with significant net outflows in the third quarter of the year. These unexpected outflows were
MoreOn Monday, major U.S. stock indexes surged, driven by optimism surrounding the start of earnings season. Additionally, transportation and small-cap stocks saw substantial gains, reflecting a risk-on sentiment among investors. Safe-haven assets
MoreFlorida lawyers may soon be required to seek their clients’ consent before utilizing artificial intelligence (AI) in their legal proceedings. The Florida Bar is currently in the process of formulating a new
MoreHealthcare payments startup Waystar Technologies has taken a significant step towards going public by publicly disclosing its filing for a U.S. stock market debut. This move comes on the heels of Waystar’s
MoreOil prices found stability on Tuesday after a dip of over $1 on the previous day. The main factors influencing this development were the growing anticipation that the United States might ease
MoreBritish e-commerce company THG (THG.L) has affirmed its annual revenue and earnings projections, which were recently revised downward. The firm disclosed that it returned to revenue growth on a constant currency basis
MorePfizer (PFE.N) announced a significant adjustment to its 2023 financial outlook, citing decreased demand for its COVID-19 vaccine and treatment. The pharmaceutical giant, which achieved record-breaking revenues in 2021 and 2022, primarily
More
